Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/022828external-prioritypatent/WO2013116065A1/en
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of MA35887B1publicationCriticalpatent/MA35887B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La présente invention concerne des composés de formule i ou leur sel pharmaceutiquement acceptable, des procédés de traitement de l'hypertriglycéridémie à l'aide desdits composés, et un procédé de préparation desdits composés.The present invention relates to compounds of formula I or their pharmaceutically acceptable salt, methods of treating hypertriglyceridemia using said compounds, and a process for preparing said compounds.
MA37245A2012-01-312014-07-24
New morpholynyl derivatives useful as mogat-2 inhibitors
MA35887B1
(en)